Press release
November 24, 2025
Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
Boundless Bio, Inc. (BOLD)
SAN DIEGO , Nov. 24, 2025 (GLOBE NEWSWIRE) -- Boundless Bio , (Nasdaq: BOLD) a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that Zachary